A Clinical Study Finds Pfizer's Dacomitinib Delays The Growth of Lung Cancer Cells Better Than AstraZeneca's Iressa Medicine & Technology Jun 06, 2017 In the last day of ASCO 2017 annual meeting on Tuesday, researchers presented the data of Dacomitinib that delayed the growth of the lung cancer longer than Gefitinib, trademarked as Iressa in newly diagnosed patients.
Extremely Powerful Solar Flare Unleashed by the Sun Triggered Widespread Radio Blackouts Across the Pacific Region
Earth's Magnetic Field Nearly Collapsed 600 Million Years Ago, Sparking Evolution of More Complex Life
Sunscreen Myths Debunked; Expert Warns Against 'Dangerous' Sun Protection Ideas That Only Puts One at Added Risk
Functional Human Brain Cells Made From Salt and Water Mark Significant Step in Iontronic Neuromorphic Computing
SPACE Is Mars Like Earth? NASA Rover Finds Substantial Amounts of Manganese on the Red Planet's Gale Crater
SPACE ‘Cosmic Glitch’ in Einstein’s Theory of General Relativity Could Be Explained in This New Scientific Tweak [Study]
SPACE Eta Aquarids 2024: Halley's Comet Meteor Shower To Peak This Weekend; Here's How To Watch the Cosmic Light Show